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Abstract
Background: Pulmonary tuberculosis (TB) patients often suffer from anorexia and poor nutrition, causing weight
loss. The peptide hormones leptin and its counterpart ghrelin, acting in the regulation of food intake and fat utilization,
play an important role in nutritional balance. This study aimed to investigate the association of blood concentrations
of leptin, ghrelin and inflammatory cytokines with body mass index (BMI) in TB patients with and without type 2
diabetes mellitus (T2DM).
Methods: BMI, biochemical parameters and plasma levels of leptin, ghrelin and inflammatory cytokines were
measured before the start of treatment in 27 incident TB patients with T2DM, 21 TB patients and 23 healthy subjects
enrolled in this study.
Results: The levels of leptin were significantly higher in TB patients (35.2±19.1 ng/ml) than TB+T2DM (12.6±6.1
ng/ml) and control (16.1±11.1 ng/ml) groups. The level of ghrelin was significantly lower in TB (119.9±46.1 pg/ml) and
non-significantly lower in TB+T2DM (127.7±38.6 pg/ml) groups than control (191.6±86.5 pg/ml) group. The levels of
TNF-α were higher, while IFN-γ and IL-6 levels were lower in patients than in the control group. Leptin showed a
negative correlation with BMI in TB (r=-0.622, p<0.05) and TB+T2DM (r= -0.654, p<0.05) groups, but a positive
correlation with BMI in the control group (r=0.521, p<0.05). Contrary ghrelin showed a positive correlation with BMI in
TB (r=0.695, p<0.05) and TB+T2DM (r= 0.199, p>0.05) groups, but negative correlation with BMI in the control
(r=-0.693, p<0.05) group. Inflammatory cytokines were poorly correlated with BMI in this study. Only IFN-γ showed a
significant negative correlation with BMI in the control group (r=-0.545, p<0.05).
Conclusions: This study may suggest that possible abnormalities in ghrelin and leptin regulation (high levels of
leptin and low levels of ghrelin) may be associated with low BMI and may account for the poor nutrition associated
with TB and TB+T2DM.
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Introduction
Pulmonary tuberculosis (TB) is a major cause of mortality
around the world, nearly one-third of the world’s population is
infected, and 8~12 million people become newly infected each
year [1]. TB incidence is influenced by several social and
economic factors, such as poverty or poor nutrition [2], as well
as by other diseases, such as diabetes mellitus (DM). Many
studies now show that DM may be associated with an
increased risk (almost triple) of developing active TB [3-5], and
TB patients who also have diabetes may have higher rates of
treatment failure and death [6,7]. China has the second highest
rate of TB morbidity in the world and DM rates are reaching
epidemic proportions [8]. This harmful synergy of TB and DM
has led public health systems in China to attempt to tackle the
two diseases concurrently. A study was initiated in which active
TB patients in poverty zones are screened for DM and the
effect of a diet and lifestyle intervention is evaluated [9].
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Poor nutrition represented by wasting and anorexia, is a
prominent feature of both TB and DM, being a hypercatabolic
state, characterised by accelerated protein degradation and
muscle wasting, resulting in weight loss, and deteriorating
clinical functions with resultant poor prognosis [4]. The
appetite-related hormones, leptin and ghrelin, may be new
candidate causes of TB-associated malnutrition [10-13]. Leptin
is a protein hormone of 167 amino acids. Its main effect relates
to energy exhaustion and control of food intake, implicated as
an anorexigenic factor that reduces appetite [14].The
connection of leptin to adipose tissue emphasizes the
endocrine function of that compartment. Conversely, ghrelin is
a 28-amino-acid peptide, which is produced by the stomach
and has recently attracted interest as a novel anti-catabolic and
orexigenic factor, that is increased in anorexic conditions and
stimulates appetite [15]. Many studies have also revealed that
both leptin and ghrelin are immune system regulators in
addition to their effect on food intake [15,16]. Plasma levels of
leptin and ghrelin can be altered in disease states associated
with anorexia [10-13]. However, previous data regarding leptin
levels in TB patients are conflicting. One study has shown that
pretreatment plasma leptin levels were lower in TB patients
than in healthy controls and there was a strong positive
correlation between leptin concentration and body mass index
(BMI) in both the control and patient group [11]. Serum leptin
level was found to be higher in TB patients than controls in
other studies [13,17] in which leptin levels were positively
related to BMI only in the control group. Ghrelin has not been
widely studied in patients with TB [18-20], let alone patients
with TB+DM. There may be increased activation of the
inflammatory system and alterations of the immune system in
TB and TB+T2DM [21-23]. Leptin and ghrelin secretion and
their circulating levels are effected by diet, adiposity, energy
balance, and hormonal factors together with many intrinsic
adiposity factors and cytokines [24]. Tumor necrosis factor-
alpha (TNF-α) shows antimycobacterial activity and promotes
granuloma formation in TB patients [25]. The increase of TNF-
α· may cause anorexia and consequent weight loss in TB
patients [26]. Interferon-gamma (IFN-γ), a Th1-type cytokine, is
known to be a key cytokine in the host immune response to
tuberculosis infection. If IFN-γ cannot be produced or cannot
exert its effects, TB infection is more severe and often fatal
[25].Some studies showed there were negative correlations
between inflammatory mediators like CRP, IL-1 and TNF-α with
BMI in patients with active lung tuberculosis [11,17,27].
However, evidence for a link between the inflammatory
response and malnutrition is still equivocal and Incomplete
[22,28]. Whether weight loss in tuberculosis is probably due to
over release of cytokines remains unknown.
This study was undertaken to investigate whether the plasma
levels of leptin, ghrelin and inflammatory cytokines are
associated with BMI (reflecting nutritional status) in TB patients
with and without type 2 diabetes (T2DM).
Materials and Methods
Ethics Statement
Permission from the ethics committee of the affiliated
hospital of Medical School of Qingdao University was obtained
before the study. And study was conducted according to the
principles outlined in the Declaration of Helsinki. Study subjects
were informed, each submitted written informed consent before
the study.
Subjects
27 patients with TB +T2DM from the Chest Hospital of
Qingdao were enrolled prospectively in this cross sectional
study. TB+T2DM patients had positive sputum culture of
mycobacterium tuberculosis and positive chest X ray, also had
a fasting plasma glucose ≥7.0 mmol/l (mM) or a random blood
sugar >11.1 mM 21 TB patients (also from chest hospital of
Qingdao) and 23 healthy subjects from medical center of the
affiliated hospital of Qingdao medical college both with similar
age and gender distribution were enrolled. Patients with type 1
diabetes, miliary TB, non-tuberculous mycobacteria (NTM), or
human immunodeficiency virus co-infection were excluded.
Patients and control subjects who had any other serious
concomitant diseases or had been previously treated with anti-
TB drugs were also excluded. Informed consent was obtained
from all subjects.
Measurements
A blood sample was collected before any treatment had
been given via a venous catheter into a Heparin Sodium tube
and non- anticoagulation tube (5ml respectively), between 7
and 8 AM after overnight fasting. After centrifugation of the
heparin sodium tube, plasma was stored at -80°C. Samples
with non-anticoagulation tubes, were water bathed for
20~30min at 37°C, and then centrifuged at 1580g for 5 min. All
biochemical analyses (including fasting plasma glucose,
hemoglobin, lipids, hepatic function parameter) in non-
anticoagulation tubes were performed on 7600-210 automatic
biochemistry analyzer (HITACHI, Inc, Japan), using Synchron
reagents provided by leadmanbio, Beijing. Blood samples
collected in the Heparin Sodium tubes for the following
assesments: plasma levels of leptin (eBioscience;
BMS2039INST, USA), total ghrelin (Millipore, EZGRA-88K,
USA), TNF-α (Peprotech; 900-M25, USA), interleukin-6 (IL-6)
(Peprotech; 900-M16, USA) and IFN-γ (Peprotech; 900-M27,
USA) were determined using enzyme-linked immuno sorbent
assay. Subjects were weighed barefoot with minimum clothing
using an electronic weighing scale, body weight was recorded
to the nearest 0.1 kg. Height was measured to the nearest 0.1
cm using stadiometer, the BMI was calculated as Weight (kg)/
height2 (m).
Statistical analysis
The sample size was estimated with a two-sided alpha of 5%
and a power of 80%. Data were tested for normal distribution
using the Kolmogorov–Smirnov test. If the distribution
appeared nonnormal, the continuous variables were
Leptin, Ghrelin, Cytokines in TB and TB+T2DM
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transformed by calculating the log10 prior to using parametric
test statistics. Results are expressed as mean±SD for normally
distributed data and geometric means for log10 transformed
data. Statistical testing for transformed variables were carried
out by ANOVA if the data were normally distributed, and by
non-parametric tests if the data were non-normally distributed.
Correlations between transformed variables were estimated
using pearson correlation coefﬁcient. Multivariate linear
regression analysis was carried out to evaluate the relationship
between the parameters. SPSS 11.5 software was used for all
statistical analyses and a p-value <0.05 was deemed
statistically significant.
Results
The anthropometric and biochemical characteristics of the 3
groups are shown in Table 1. TB (23.0±4.3 kg/m2) and
particularly TB+T2DM (22.2±3.5 kg/m2) groups had lower levels
of BMI than the control group (24.8±3.6 kg/m2). TB+T2DM
showed a higher level of serum glucose than TB and control
groups (10.6±4.4 versus 5.1±0.5 mM, 10.6±4.4 versus 5.2±0.5
mM, respectively, p<0.05). The control group had higher level
of HDL-cholesterol, proteins and uric acid than patients groups
(p<0.05).
The levels of peptide hormones and inflammatory cytokines
are shown in Table 2. The level of leptin was significantly
higher in TB patients than in TB+T2DM and control groups
(35.2±19.1 versus 12.6±6.1 ng/ml, 35.2±19.1 versus16.1±11.1
ng/ml respectively, p<0.05), while the level of ghrelin was lower
in TB (119.9±46.1 pg/ml) and TB+T2DM (127.7±38.6 pg/ml)
groups compared with control group (191.6±86.5 pg/ml). Levels
of TNF-α were higher in TB and TB+T2DM compared with
control group (486.9±30.4 versus 340.9±23.6 pg/ml, p>0.05;
616.0±24.9 versus 340.9±23.6 pg/ml, p<0.05). Levels of IL-6
were higher in control group but the differences were not
significant. Levels of IFN-γ were lower in TB and TB+T2DM
compared with control group (2278.7±929.2 versus
Table 1. Characteristics of the study subjects (N= 71).
 TB TB+ T2DM Control
N(male/female) 21(17/4) 27(23/4) 23(20/3)
Age(years) 50.2±10.9 52.9±10.3 49.4±15.6
BMI(kg/m2) 23.0±4.3 22.2±3.5 c 24.8±3.6
Glucose(mM) 5.1±0.5 10.6±4.4 a, c 5.2±0.5
Cholesterol(mM) 5.9±7.6 4.4±1.3 4.7±0.8
Triglycerides(mM) 1.1±0.2 1.12±0.5 1.1±0.3
VLDL-cholesterol(mM) 2.6±0.7 2.3±0.7 2.2±0.3
HDL-cholesterol(mM) 1.1±0.3 b 1.2±0.3 c 1.3±0.3
Total protein(mM) 62.6±7.5 b 63.9±7.6 c 75.9±4.1
Albumin(mM) 39.1±7.0 b 37.9±5.4 c 43.8±2.4
Results are expressed as mean±SD.
Abbreviations: BMI, body mass index; VLDL, very low-density lipoprotein; HDL,
high-density lipoprotein.
a. Compared TB with TB+T2DM，p<0.05; b: Compared TB with Control，p<0.05 c:
Compared TB+T2DM with Control, p<0.05.
doi: 10.1371/journal.pone.0080122.t001
4020.7±838.5 pg/ml, p<0.05; 3501.2±488.3 versus
4020.7±838.5 pg/ml, p>0.05).
Table 3 shows the correlation of appetite-related hormones
and inflammatory cytokines with BMI among the 3 groups.
Leptin showed a negative correlation with BMI in TB (r=-0.622,
p<0.05) and TB+T2DM (r= -0.654, p<0.05) groups, but positive
correlation with BMI in control group (r=0.521, p<0.05). Ghrelin
showed positive correlation with BMI in the TB (r=0.695,
p<0.05) and TB+T2DM (r= 0.199, p>0.05) groups, but negative
correlation with BMI in control group (r=-0.693, p<0.05). There
were positive nonsignificant correlations for all 3 cytokines in
the TB group, negative nonsignificant correlations for TNF-α
and IFN-γ and a positive nonsignificant correlation for IL-6 in
the TB+T2DM group. In the control group, all correlations were
negative and nonsignificant, except for IFN-γ (r=-0.545,
p<0.05).
Multivariate linear regression of BMI as dependent variable
with age, sex, appetite-related hormones and inflammatory
cytokines in the three groups are showen in Table 4. Leptin
was significantly inversely associated with BMI in the TB
(p=0.009) and TB+T2DM (p=0.012) groups, but positively in the
control group (p=0.436). Ghrelin had a significant positive
association with BMI in the TB (p=0.026) and TB+T2DM
Table 2. Circulating levels of appetite-related hormones
and inflammatory cytokines in patients and healthy subjects
(N= 71).
 TB TB+ T2DM Control
N 21 27 23
Leptin(ng/ml) 35.2±19.1 a ,b 12.6±6.1 16.1±11.1
Ghrelin(pg/ml) 119.9±46.1 b 127.7±38.6 191.6±86.5
TNF-α(pg/ml) 486.9±30.4 616.0±24.9 c 340.9±23.6
LogIL-6(pg/ml) 24.2(19.6-28.8) 26.8(22.8-30.8) 29.9(25.0-30.8)
IFN-γ(pg/ml) 2278.7±929.2 b 3501.2±488.3 4020.7±838.5
Values are mean±SD, and geometric mean (95% CI) for Log IL-6.
Abbreviations: IL-6, interleukin-6; TNF-α, denotes tissue necrosis factor-α; IFN-
γ,,interferon-γ.
a. Compared TB with TB+T2DM，p<0.05; b: Compared TB with Control，p<0.05 c:
Compared TB+T2DM with Control, p<0.05.
doi: 10.1371/journal.pone.0080122.t002
Table 3. Correlation of characteristics with BMI among
different groups.
 TB TB+ T2DM Control
N 21 27 23
Leptin -0.622* -0.654* 0.521*
Ghrelin 0.695* 0.199 -0.693*
TNF-α 0.163 -0.085 -0.350
Log10IL-6 0.293 0.364 -0.313
IFN-γ 0.205 -0.211 -0.545*
Abbreviations: IL-6, interleukin-6; TNF-α, denotes tissue necrosis factor-α; IFN-γ,
interferon-γ * p<0.05.
doi: 10.1371/journal.pone.0080122.t003
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(p=0.049) groups, but an inverse association in the control
group (p=0.233). There were no important associations
between BMI and age, sex, inflammatory cytokines in 3 groups
respectively. Leptin was the major factor affecting BMI in the
TB group, while ghrelin was the major factor in the TB+T2DM
group.
Discussion
In our study, we found TB patients with or without T2DM had
a worse nutritional status (lower BMI and plasma protein levels)
than controls. Our results demonstrate that plasma leptin levels
were significantly higher in the TB group compared to the TB
+T2DM and control groups, whereas levels of plasma ghrelin
were lower in patients than in the control group. The
association with BMI was negative for leptin and positive for
ghrelin in the patients whereas these associations were
opposite in control group. Levels of TNF-α were higher and
IFN-γ were lower in the patients compared with the controls.
However, in mulivariate analysis, the association of leptin and
ghrelin with BMI was not explained by the cytokines.
Our study examined not only TB and healthy subjects, but
TB+T2DM patients as well, a group which has rarely received
attention until now. This relates to the special situation in China
where TB and DM constitute a double-burden. Patients in our
study were not yet treated by anti-tuberculosis drugs.
Limitations were the relatively small sample size, and the small
number females within group, so the sex effect on related
hormones and inflammatory cytokines could not be
investigated. We have measured total ghrelin levels in the
plasma, which contains both “active” and “inactive” forms.
However, it has been reported that total ghrelin levels can
reflect the level of the active form in the plasma [29,30]. In this
study, we chose BMI as a correlate of body fat. The hospital in
our area could not afford equipment to measure the percent
body fat. Otherwise, body fat estimated from skinfold thickness
is dependent on accurate measurements at the right sites
(biceps, triceps, subscapular, and suprailiac regions), this
requires skillful staff to carry out the work. However, patients in
our study were mainly from counties and villages in poor rural
areas, and although skinfold thickness was measured, it was
difficult to train local staffs to perform standardized
measurements for percent body fat measurement. According to
many reports, BMI could effectively predict the percentage of
body fat. Suchanek P et al [31] aimed to compare estimates of
body fat content, like BMI, body adiposity index (BAI), waist-hip
ratio (WHR), with respect to their ability to predict the
percentage of body fat. They found BMI index was the better
universally valid index to predict the percentage of body fat
than BAI index and WHR index. Also others reported a good
correlation of BMI and percentage of body fat especially in
Asian. The correlation coefficient (R) could go up to 0.90 [32].
Researchers in China also made many investigations to
evaluate the possibilities to use BMI as predictor of body fat
status and diseases caused by obesity [33–35]. With respect to
difference according to race, Asian people have less muscle
and skeleton tissue than westerns with the same BMI, and the
percentage of body fat is higher. So given the quality of the
skinfold thickness measurements in our study and based on
the reports of correlation between BMI and body fat in Asians,
we prefer to use BMI as a correlate of body fat applicable to
individuals in China.
TNF-α induces fever and weight loss, which are prominent
symptoms of TB. It has been shown to be associated with both
protection and pathogenesis in mycobacterial infections [36].
Raised concentrations of TNF-α may underly much of the
metabolic clustering due to diabetes mellitus [37]. In our study,
the level of TNF-α was higher in TB patients, especially those
with T2DM. This finding may suggest that mycobacterium
tuberculosis (MTB), mainly multiplying in macrophages ，
stimulates TNF-α release, especially in the presence of high
glucose concentrations. IFN-γ as one of the typical Th1
cytokines is a key cytokine in the host immune response to
tuberculosis infection. We found that TB patients with or
without T2DM had lower levels of IFN-γ than controls like
others reported [38], which may indicate that they have a
weaker defense against tuberculosis infection.
Leptin is mainly synthesized by adipose tissue. But under
inflammatory conditions, one study suggested a ‘‘cytokine–
leptin hypothesis’’ implying that higher multiple cytokine levels
are correlated with increased leptin levels [39]. In the TB
patient group, we found higher levels of TNF-α and leptin
compared to the control group. However, the TB+T2DM group
had higher levels of TNF-α in combination with lower leptin
levels compared to the control group in our study. Experimental
studies showed that the leptin levels in patients with type 2
diabetes are diverse and seem to be related to the duration of
the disease. In subjects with poorly controlled type 2 diabetes
who lost weight rapidly, with lower levels of BMI and leptin,
levels of TNF-α were reported to be higher than in controls
[40,41]. So possibly in patients with type 2 diabetes, leptin and
TNF-α status can not be explained by the ‘‘cytokine–leptin
hypothesis’’. Therefore in TB patients with T2DM, the
pathogenesis of wasting may be different. To our knowledge
there have been no reports in the literature on this. Maybe
there is a more complicated mechanism at work when TB and
Table 4. Multivariate linear regression of BMI with age, sex,
appetite-related hormones and inflammatory cytokines in
different groups.








Age(year) -0.025 0.731 -0.006 0.916 -0.007 0.913
Sex 2.234 0.218 0.236 0.913 0.018 0.990
Leptin(ng/ml) -3.873 0.009 -0.164 0.012 0.037 0.436
Ghrelinpg/ml) 1.341 0.026 0.531 0.049 -0.330 0.233
TNF-α(pg/ml) 0.00 0.874 0.001 0.791 0.001 0.891
Log10IL-6(pg/m
l) 0.082 0.299 0.109 0.086 -0.065 0.278
IFN-γ(pg/ml) 0.113 0.156 0.002 0.976 -0.110 0.174
Dependent Variable: BMI. Abbreviations: IL-6, interleukin-6; TNF-α, denotes tissue
necrosis factor-α; IFN-γ,interferon-γ.
doi: 10.1371/journal.pone.0080122.t004
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T2DM are combined. Leptin may be an important factor
involved in the mechanism behind wasting, because both in TB
patients with and without T2DM, leptin showed a negative
correlation with BMI. Two articles [18,20] found that ghrelin in
TB patients is elevated compared to controls, and correlates
negatively with BMI [20]. But Kim et al [19] found that plasma
ghrelin levels were significantly lower in malnourished patients
than in well nourished patients with TB before treatment. In
correlation analysis, ghrelin levels were negatively correlated to
the malnutrition score. Our results were similar showing a
positive correlation of ghrelin with BMI in TB and TB+T2DM
groups as Kim et al [19].
Interestingly, the correlation of leptin and ghrelin with BMI in
the patient groups is contrary to what is observed in the healthy
control group where it is correlated with the amount of fat
tissue.as reported in the literature [13,17]. In TB patients high
leptin levels may be a cause of the low BMI instead of being a
consequence of the amount of fat tissue. Inflammatory
cytokines were poorly correlated with BMI in our patients,
although there was a negative association of leptin and TNF-α
with BMI. Cakir B et al [17] have found increased and
correlated levels of TNF-α and leptin in tuberculosis patients,
and his interpretation was that the elevated leptin level leads to
weight loss, and through that may contribute to the
inflammatory process. However, Kim JH et al [19] found higher
levels of TNF-α in the TB group, that were poorly correlated
with weight loss, whereas leptin levels were positively
correlated with TNF-α, although not statistically significant.
Combined with our findings, higher levels of leptin and TNF-α
may indicate that although TNF-α may correlate with leptin, it is
not directly responsible for the lower BMI. Although some
reports have shown that plasma TNF-α levels are associated
with weight loss in TB, we were unable to demonstrate this.
Although high inflammatory status maybe primarily responsible
for low BMI in patients with TB, low BMI in TB cannot be
explained by the investigated inflammatory cytokines only
[21,42]. This may suggest that externalization of leptin and
ghrelin in these patients is not determined by nutritional status
(amount of fat tissue), but in fact is a causal factor in the
development of low BMI. The effect of leptin and ghrelin on
BMI seems to be largely independent of the investigated
cytokines. Further studies are needed to investigate the
complex mechanisms.
Conclusions
This study provides novel evidence of status and relationship
between appetite-related hormones, inflammatory cytokines
and BMI in TB patients with or without T2DM. We conclude that
possible abnormalities in leptin and ghrelin regulation may be
associated with the development of poor nutrition (low BMI)
during the inflammatory response in TB patients with or without
T2DM. TB patients with T2DM may have more complex and
different pathogenesis compared to TB patients only. Given the
complexity of the interaction of appetite-related hormones and
cytokines, further studies are needed to clarify this issue and
underlying mechanisms.
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